Health Condition 1: 1- Obstetrics
Conditions
Interventions
Intervention1: ASTAXANTHIN: ANTIOXIDANT PROPERTIES
Control Intervention1: NIL: NIL
Sponsors
SAVEETHA PREGNANCY REJUVENATION AND OVULATORY UTERINE THERAPEUTICS
Eligibility
Inclusion criteria
Inclusion criteria: Male patients aged 20 TO 50 years Diagnosed with oligospermia asthenozoospermia teratozoospermia or high sperm DNA fragmentation index No prior antioxidant supplementation for at least three months before enrollment Willingness to comply with study protocol and provide informed consent
Exclusion criteria
Exclusion criteria: Presence of severe systemic diseases such as diabetes or cardiovascular disorders affecting sperm quality History of smoking excessive alcohol consumption or substance abuse Patients with azoospermia or other irreversible causes of infertility Use of hormonal therapy or medications known to affect sperm quality within three monthS
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Correlate improvements in semen parameters with clinical pregnancy rates and patients reported satisfaction regarding treatment.Timepoint: 3 MONTHS | — |
Secondary
| Measure | Time frame |
|---|---|
| By reducing oxidative stress & DNA fragmentation the study could support healthier sperm leading to better embryo quality & reduced miscarriage risk.Timepoint: 3 MONTHS | — |
Countries
India
Contacts
Public ContactMOKITH A
SAVEETHA INSTITUTE OF MEDICAL AND TECHNICAL SCIENCE
Outcome results
None listed